 | • レポートコード：D005-00791 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、膵臓ベータ細胞保護の世界市場を広く調査・分析し、今後の市場展望をまとめております。膵臓ベータ細胞保護の種類別市場規模（幹細胞ベース、遺伝子治療、RNAベース治療、モノクローナル抗体（MAb）、植物療法）、用途別市場規模（病院、医学研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：ViaCyte、Pfizer Inc、GalaxoSmithKline、PharmaCyte Biotech、Janssen Research & Development、Boehringer Ingelheim、Genentech、Novartis、Beta-Cell NV、BioLineRx、Transition Therapeutics、Novo Nordisk、Beta-O2 Technologies Ltd、Sanofi、Osiris Therapeutics ・地域別グローバル市場分析 2015年-2020年 ・膵臓ベータ細胞保護の北米市場（アメリカ、カナダ、メキシコ） ・膵臓ベータ細胞保護のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・膵臓ベータ細胞保護のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・膵臓ベータ細胞保護の南米市場（ブラジル、アルゼンチン） ・膵臓ベータ細胞保護の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：幹細胞ベース、遺伝子治療、RNAベース治療、モノクローナル抗体（MAb）、植物療法 ・用途別分析：病院、医学研究所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Pancreatic Beta-Cell Protection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Pancreatic Beta-Cell Protection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pancreatic Beta-Cell Protection market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pancreatic Beta-Cell Protection market has been segmented into:
Stem Cell Based
Gene Therapies
RNA Based Therapies
Monoclonal Antibodies (MAbs)
Phytotherapy
By Application, Pancreatic Beta-Cell Protection has been segmented into:
Hospital
Medical Research Laboratory
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pancreatic Beta-Cell Protection market presented in the report. This section sheds light on the sales growth of different regional and country-level Pancreatic Beta-Cell Protection markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pancreatic Beta-Cell Protection market.
The report offers in-depth assessment of the growth and other aspects of the Pancreatic Beta-Cell Protection market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Pancreatic Beta-Cell Protection Market Share Analysis
Pancreatic Beta-Cell Protection competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pancreatic Beta-Cell Protection sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pancreatic Beta-Cell Protection sales, revenue and market share for each player covered in this report.
The major players covered in Pancreatic Beta-Cell Protection are:
ViaCyte
Pfizer Inc
GalaxoSmithKline
PharmaCyte Biotech
Janssen Research & Development
Boehringer Ingelheim
Genentech
Novartis
Beta-Cell NV
BioLineRx
Transition Therapeutics
Novo Nordisk
Beta-O2 Technologies Ltd
Sanofi
Osiris Therapeutics
Table of Contents
1 Pancreatic Beta-Cell Protection Market Overview
1.1 Product Overview and Scope of Pancreatic Beta-Cell Protection
1.2 Classification of Pancreatic Beta-Cell Protection by Type
1.2.1 Global Pancreatic Beta-Cell Protection Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pancreatic Beta-Cell Protection Revenue Market Share by Type in 2019
1.2.3 Stem Cell Based
1.2.4 Gene Therapies
1.2.5 RNA Based Therapies
1.2.6 Monoclonal Antibodies (MAbs)
1.2.7 Phytotherapy
1.3 Global Pancreatic Beta-Cell Protection Market by Application
1.3.1 Overview: Global Pancreatic Beta-Cell Protection Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Global Pancreatic Beta-Cell Protection Market by Regions
1.4.1 Global Pancreatic Beta-Cell Protection Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pancreatic Beta-Cell Protection (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pancreatic Beta-Cell Protection Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pancreatic Beta-Cell Protection Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pancreatic Beta-Cell Protection Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pancreatic Beta-Cell Protection Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pancreatic Beta-Cell Protection Status and Prospect (2015-2025)
2 Company Profiles
2.1 ViaCyte
2.1.1 ViaCyte Details
2.1.2 ViaCyte Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 ViaCyte SWOT Analysis
2.1.4 ViaCyte Product and Services
2.1.5 ViaCyte Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer Inc
2.2.1 Pfizer Inc Details
2.2.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer Inc SWOT Analysis
2.2.4 Pfizer Inc Product and Services
2.2.5 Pfizer Inc Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.3 GalaxoSmithKline
2.3.1 GalaxoSmithKline Details
2.3.2 GalaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GalaxoSmithKline SWOT Analysis
2.3.4 GalaxoSmithKline Product and Services
2.3.5 GalaxoSmithKline Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.4 PharmaCyte Biotech
2.4.1 PharmaCyte Biotech Details
2.4.2 PharmaCyte Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 PharmaCyte Biotech SWOT Analysis
2.4.4 PharmaCyte Biotech Product and Services
2.4.5 PharmaCyte Biotech Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.5 Janssen Research & Development
2.5.1 Janssen Research & Development Details
2.5.2 Janssen Research & Development Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Janssen Research & Development SWOT Analysis
2.5.4 Janssen Research & Development Product and Services
2.5.5 Janssen Research & Development Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim SWOT Analysis
2.6.4 Boehringer Ingelheim Product and Services
2.6.5 Boehringer Ingelheim Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.7 Genentech
2.7.1 Genentech Details
2.7.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Genentech SWOT Analysis
2.7.4 Genentech Product and Services
2.7.5 Genentech Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.9 Beta-Cell NV
2.9.1 Beta-Cell NV Details
2.9.2 Beta-Cell NV Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Beta-Cell NV SWOT Analysis
2.9.4 Beta-Cell NV Product and Services
2.9.5 Beta-Cell NV Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.10 BioLineRx
2.10.1 BioLineRx Details
2.10.2 BioLineRx Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 BioLineRx SWOT Analysis
2.10.4 BioLineRx Product and Services
2.10.5 BioLineRx Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.11 Transition Therapeutics
2.11.1 Transition Therapeutics Details
2.11.2 Transition Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Transition Therapeutics SWOT Analysis
2.11.4 Transition Therapeutics Product and Services
2.11.5 Transition Therapeutics Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.12 Novo Nordisk
2.12.1 Novo Nordisk Details
2.12.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Novo Nordisk SWOT Analysis
2.12.4 Novo Nordisk Product and Services
2.12.5 Novo Nordisk Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.13 Beta-O2 Technologies Ltd
2.13.1 Beta-O2 Technologies Ltd Details
2.13.2 Beta-O2 Technologies Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Beta-O2 Technologies Ltd SWOT Analysis
2.13.4 Beta-O2 Technologies Ltd Product and Services
2.13.5 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Sanofi SWOT Analysis
2.14.4 Sanofi Product and Services
2.14.5 Sanofi Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
2.15 Osiris Therapeutics
2.15.1 Osiris Therapeutics Details
2.15.2 Osiris Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Osiris Therapeutics SWOT Analysis
2.15.4 Osiris Therapeutics Product and Services
2.15.5 Osiris Therapeutics Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pancreatic Beta-Cell Protection Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pancreatic Beta-Cell Protection Players Market Share
3.2.2 Top 10 Pancreatic Beta-Cell Protection Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pancreatic Beta-Cell Protection Revenue and Market Share by Regions
4.2 North America Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
4.3 Europe Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
4.5 South America Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
5 North America Pancreatic Beta-Cell Protection Revenue by Countries
5.1 North America Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020)
5.2 USA Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
5.3 Canada Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
5.4 Mexico Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
6 Europe Pancreatic Beta-Cell Protection Revenue by Countries
6.1 Europe Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020)
6.2 Germany Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
6.3 UK Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
6.4 France Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
6.5 Russia Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
6.6 Italy Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pancreatic Beta-Cell Protection Revenue by Countries
7.1 Asia-Pacific Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020)
7.2 China Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
7.3 Japan Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
7.4 Korea Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
7.5 India Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
8 South America Pancreatic Beta-Cell Protection Revenue by Countries
8.1 South America Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020)
8.2 Brazil Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
8.3 Argentina Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pancreatic Beta-Cell Protection by Countries
9.1 Middle East & Africa Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
9.3 UAE Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
9.4 Egypt Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
9.5 South Africa Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pancreatic Beta-Cell Protection Revenue and Market Share by Type (2015-2020)
10.2 Global Pancreatic Beta-Cell Protection Market Forecast by Type (2019-2024)
10.3 Stem Cell Based Revenue Growth Rate (2015-2025)
10.4 Gene Therapies Revenue Growth Rate (2015-2025)
10.5 RNA Based Therapies Revenue Growth Rate (2015-2025)
10.6 Monoclonal Antibodies (MAbs) Revenue Growth Rate (2015-2025)
10.7 Phytotherapy Revenue Growth Rate (2015-2025)
11 Global Pancreatic Beta-Cell Protection Market Segment by Application
11.1 Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2015-2020)
11.2 Pancreatic Beta-Cell Protection Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Medical Research Laboratory Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Pancreatic Beta-Cell Protection Market Size Forecast (2021-2025)
12.1 Global Pancreatic Beta-Cell Protection Market Size Forecast (2021-2025)
12.2 Global Pancreatic Beta-Cell Protection Market Forecast by Regions (2021-2025)
12.3 North America Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025)
12.4 Europe Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025)
12.6 South America Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Pancreatic Beta-Cell Protection Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pancreatic Beta-Cell Protection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pancreatic Beta-Cell Protection Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Pancreatic Beta-Cell Protection Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. ViaCyte Corporate Information, Location and Competitors
Table 6. ViaCyte Pancreatic Beta-Cell Protection Major Business
Table 7. ViaCyte Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 8. ViaCyte SWOT Analysis
Table 9. ViaCyte Pancreatic Beta-Cell Protection Product and Solutions
Table 10. ViaCyte Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pfizer Inc Corporate Information, Location and Competitors
Table 12. Pfizer Inc Pancreatic Beta-Cell Protection Major Business
Table 13. Pfizer Inc Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2018-2019)
Table 14. Pfizer Inc SWOT Analysis
Table 15. Pfizer Inc Pancreatic Beta-Cell Protection Product and Solutions
Table 16. Pfizer Inc Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. GalaxoSmithKline Corporate Information, Location and Competitors
Table 18. GalaxoSmithKline Pancreatic Beta-Cell Protection Major Business
Table 19. GalaxoSmithKline Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 20. GalaxoSmithKline SWOT Analysis
Table 21. GalaxoSmithKline Pancreatic Beta-Cell Protection Product and Solutions
Table 22. GalaxoSmithKline Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. PharmaCyte Biotech Corporate Information, Location and Competitors
Table 24. PharmaCyte Biotech Pancreatic Beta-Cell Protection Major Business
Table 25. PharmaCyte Biotech Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 26. PharmaCyte Biotech SWOT Analysis
Table 27. PharmaCyte Biotech Pancreatic Beta-Cell Protection Product and Solutions
Table 28. PharmaCyte Biotech Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Janssen Research & Development Corporate Information, Location and Competitors
Table 30. Janssen Research & Development Pancreatic Beta-Cell Protection Major Business
Table 31. Janssen Research & Development Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 32. Janssen Research & Development SWOT Analysis
Table 33. Janssen Research & Development Pancreatic Beta-Cell Protection Product and Solutions
Table 34. Janssen Research & Development Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 36. Boehringer Ingelheim Pancreatic Beta-Cell Protection Major Business
Table 37. Boehringer Ingelheim Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 38. Boehringer Ingelheim SWOT Analysis
Table 39. Boehringer Ingelheim Pancreatic Beta-Cell Protection Product and Solutions
Table 40. Boehringer Ingelheim Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Genentech Corporate Information, Location and Competitors
Table 42. Genentech Pancreatic Beta-Cell Protection Major Business
Table 43. Genentech Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 44. Genentech SWOT Analysis
Table 45. Genentech Pancreatic Beta-Cell Protection Product and Solutions
Table 46. Genentech Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Novartis Corporate Information, Location and Competitors
Table 48. Novartis Pancreatic Beta-Cell Protection Major Business
Table 49. Novartis Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 50. Novartis SWOT Analysis
Table 51. Novartis Pancreatic Beta-Cell Protection Product and Solutions
Table 52. Novartis Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Beta-Cell NV Corporate Information, Location and Competitors
Table 54. Beta-Cell NV Pancreatic Beta-Cell Protection Major Business
Table 55. Beta-Cell NV Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 56. Beta-Cell NV SWOT Analysis
Table 57. Beta-Cell NV Pancreatic Beta-Cell Protection Product and Solutions
Table 58. Beta-Cell NV Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. BioLineRx Corporate Information, Location and Competitors
Table 60. BioLineRx Pancreatic Beta-Cell Protection Major Business
Table 61. BioLineRx Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 62. BioLineRx SWOT Analysis
Table 63. BioLineRx Pancreatic Beta-Cell Protection Product and Solutions
Table 64. BioLineRx Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Transition Therapeutics Corporate Information, Location and Competitors
Table 66. Transition Therapeutics Pancreatic Beta-Cell Protection Major Business
Table 67. Transition Therapeutics Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 68. Transition Therapeutics SWOT Analysis
Table 69. Transition Therapeutics Pancreatic Beta-Cell Protection Product and Solutions
Table 70. Transition Therapeutics Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Novo Nordisk Corporate Information, Location and Competitors
Table 72. Novo Nordisk Pancreatic Beta-Cell Protection Major Business
Table 73. Novo Nordisk Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 74. Novo Nordisk SWOT Analysis
Table 75. Novo Nordisk Pancreatic Beta-Cell Protection Product and Solutions
Table 76. Novo Nordisk Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Beta-O2 Technologies Ltd Corporate Information, Location and Competitors
Table 78. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Major Business
Table 79. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 80. Beta-O2 Technologies Ltd SWOT Analysis
Table 81. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Product and Solutions
Table 82. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Sanofi Corporate Information, Location and Competitors
Table 84. Sanofi Pancreatic Beta-Cell Protection Major Business
Table 85. Sanofi Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 86. Sanofi SWOT Analysis
Table 87. Sanofi Pancreatic Beta-Cell Protection Product and Solutions
Table 88. Sanofi Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Osiris Therapeutics Corporate Information, Location and Competitors
Table 90. Osiris Therapeutics Pancreatic Beta-Cell Protection Major Business
Table 91. Osiris Therapeutics Pancreatic Beta-Cell Protection Total Revenue (USD Million) (2017-2018)
Table 92. Osiris Therapeutics SWOT Analysis
Table 93. Osiris Therapeutics Pancreatic Beta-Cell Protection Product and Solutions
Table 94. Osiris Therapeutics Pancreatic Beta-Cell Protection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global Pancreatic Beta-Cell Protection Revenue (Million USD) by Players (2015-2020)
Table 96. Global Pancreatic Beta-Cell Protection Revenue Share by Players (2015-2020)
Table 97. Global Pancreatic Beta-Cell Protection Revenue (Million USD) by Regions (2015-2020)
Table 98. Global Pancreatic Beta-Cell Protection Revenue Market Share by Regions (2015-2020)
Table 99. North America Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020)
Table 100. North America Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020)
Table 101. Europe Pancreatic Beta-Cell Protection Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific Pancreatic Beta-Cell Protection Revenue (Million USD) by Countries (2015-2020)
Table 103. South America Pancreatic Beta-Cell Protection Revenue by Countries (2015-2020)
Table 104. South America Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Pancreatic Beta-Cell Protection Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020)
Table 107. Global Pancreatic Beta-Cell Protection Revenue (Million USD) by Type (2015-2020)
Table 108. Global Pancreatic Beta-Cell Protection Revenue Share by Type (2015-2020)
Table 109. Global Pancreatic Beta-Cell Protection Revenue Forecast by Type (2021-2025)
Table 110. Global Pancreatic Beta-Cell Protection Revenue by Application (2015-2020)
Table 111. Global Pancreatic Beta-Cell Protection Revenue Share by Application (2015-2020)
Table 112. Global Pancreatic Beta-Cell Protection Revenue Forecast by Application (2021-2025)
Table 113. Global Pancreatic Beta-Cell Protection Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Pancreatic Beta-Cell Protection Picture
Figure 2. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type in 2019
Figure 3. Stem Cell Based Picture
Figure 4. Gene Therapies Picture
Figure 5. RNA Based Therapies Picture
Figure 6. Monoclonal Antibodies (MAbs) Picture
Figure 7. Phytotherapy Picture
Figure 8. Pancreatic Beta-Cell Protection Revenue Market Share by Application in 2019
Figure 9. Hospital Picture
Figure 10. Medical Research Laboratory Picture
Figure 11. Others Picture
Figure 12. Global Pancreatic Beta-Cell Protection Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Pancreatic Beta-Cell Protection Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Pancreatic Beta-Cell Protection Revenue Market Share in 2019
Figure 21. Global Top 10 Players Pancreatic Beta-Cell Protection Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Pancreatic Beta-Cell Protection Revenue Market Share by Regions (2015-2020)
Figure 25. Global Pancreatic Beta-Cell Protection Revenue Market Share by Regions in 2018
Figure 26. North America Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 27. Europe Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 29. South America Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 31. North America Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020)
Figure 32. North America Pancreatic Beta-Cell Protection Revenue Market Share by Countries in 2019
Figure 33. USA Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 34. Canada Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 36. Europe Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Pancreatic Beta-Cell Protection Revenue Market Share by Countries in 2019
Figure 38. Germany Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 39. UK Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 40. France Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 41. Russia Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 42. Italy Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Pancreatic Beta-Cell Protection Revenue Market Share by Countries in 2019
Figure 45. China Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 46. Japan Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 47. Korea Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 48. India Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 50. South America Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020)
Figure 51. South America Pancreatic Beta-Cell Protection Revenue Market Share by Countries in 2019
Figure 52. Brazil Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Pancreatic Beta-Cell Protection Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Pancreatic Beta-Cell Protection Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 57. UAE Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Pancreatic Beta-Cell Protection Revenue and Growth Rate (2015-2020)
Figure 60. Global Pancreatic Beta-Cell Protection Revenue Share by Type (2015-2020)
Figure 61. Global Pancreatic Beta-Cell Protection Revenue Share by Type in 2019
Figure 62. Global Pancreatic Beta-Cell Protection Market Share Forecast by Type (2021-2025)
Figure 63. Global Stem Cell Based Revenue Growth Rate (2015-2020)
Figure 64. Global Gene Therapies Revenue Growth Rate (2015-2020)
Figure 65. Global RNA Based Therapies Revenue Growth Rate (2015-2020)
Figure 66. Global Monoclonal Antibodies (MAbs) Revenue Growth Rate (2015-2020)
Figure 67. Global Phytotherapy Revenue Growth Rate (2015-2020)
Figure 68. Global Pancreatic Beta-Cell Protection Revenue Share by Application (2015-2020)
Figure 69. Global Pancreatic Beta-Cell Protection Revenue Share by Application in 2019
Figure 70. Global Pancreatic Beta-Cell Protection Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospital Revenue Growth Rate (2015-2020)
Figure 72. Global Medical Research Laboratory Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Pancreatic Beta-Cell Protection Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Pancreatic Beta-Cell Protection Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Pancreatic Beta-Cell Protection Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025)
Figure 78. Europe Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025)
Figure 80. South America Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Pancreatic Beta-Cell Protection Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
外分泌膵機能不全の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Exocrine Pancreatic Insufficiency market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 2402.2 million by 2025, from USD 2073.7 million in 2019. The Ex…- 膵臓ステントの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pancreatic Stent market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pancreatic Stent market repo…
- グラフェン系色素増感太陽電池の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Graphene-Based Dye-Sensitized Solar Cell market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Grap…
- 前駆細胞製品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Progenitor Cell Product market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Progenitor Cell Produ…
- 細胞分離の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cell Separation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cell Separation market report…